Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2015 / 0415
April 2015

April 2015

Top 40 Under 40

Download PDF
All Issues

5 Things We Learned This Month:

June 9, 2015

1 min read

5 Things We Learned This Month:

Freedom Fighter

April 15, 2015

Sitting Down With… David Pyott, Chairman of the Board and Chief Executive Officer of Allergan, Inc.

1 min read

Freedom Fighter

Dry Eye Disease’s Diagnostic Challenge

April 14, 2015

The multifactorial nature of dry eye disease means that often, there’s a discordance between signs and symptoms, confounding diagnosis. Can things be improved?

1 min read

Dry Eye Disease’s Diagnostic Challenge

Look How Far We’ve Come

April 14, 2015

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.

1 min read

Look How Far We’ve Come

The BMJ Bevacizumab Brouhaha

April 13, 2015

Novartis “embarked on a campaign to undermine” the use of bevacizumab in wet AMD, a BMJ investigation alleges.

1 min read

The BMJ Bevacizumab Brouhaha

Picketing Parliament

April 13, 2015

Ophthalmologists and other eye health stakeholders lobby UK Parliament to implement improved sight loss and eye health services

1 min read

Picketing Parliament

A Penny Pusher Model of Lens Growth

April 13, 2015

New research shows that lens epithelial cells proliferate along a narrow line, pushing older cells toward the equator and then the center of the lens

1 min read

A Penny Pusher Model of Lens Growth

Classifying Keratoconus – Classically

April 13, 2015

There’s still a place for retinoscopy in the diagnosis and staging of corneal ectasias

1 min read

Classifying Keratoconus – Classically

Reducing Corneal Graft Rejection on a Very Small Scale

April 13, 2015

Nanoparticles deliver sustained corticosteroid levels to prevent corneal graft rejection

1 min read

Reducing Corneal Graft Rejection on a Very Small Scale

3-D Printed Prosections

April 13, 2015

Inexpensive, high-resolution 3D printouts of orbital prosections can help ophthalmology trainees revisit basic anatomy

1 min read

3-D Printed Prosections

The Value of The List

April 13, 2015

We run the Power List to contribute, not to be controversial.

1 min read

The Value of The List

Browse by Subspecialties

Cataract Cornea Glaucoma Neuro-ophthalmology Oculoplastics Optometry Pediatric Retina

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: